A new generation of medicinal products derived from HemaGel

Scientists from the Institute of Macromolecular Chemistry of the CAS have developed a new generation of medicinal products derived from the original product used to accelerate the healing of injuries called HemaGel. Medicinal products manufacturer company VH Pharma will launch gel HemaGel New and its new application HemaCut SPRAY this year. Both new medicinal products have been protected by patents.

The new generation of medicinal products derived from the original product HemaGel is the result of the long-term cooperation of polymer chemists from the Institute of Macromolecular Chemistry of the CAS with the company VH Pharma.

Chemists from the IMC have improved the structure of HemaGel and developed a new spray application. "Both new products contain an active polymer that can scavenge harmful oxygen radicals in the wound, effectively suppressing inflammation. The polymer is made up of large macromolecules, interconnected into networks. This arrangement prevents passing of the polymer through the skin into the body and keeps it on the surface of the wound, where it can act for a long time," explains Zdeňka Sedláková, Head of the Department of Controlled Polymer Synthesis, which deals with the development of hydrophilic gels at the IMC.

HemaGel NEW forms a hydrogel based on a newly developed IPN polymer network. Thanks to its unique properties, the hydrogel requires optimal conditions for healing that have anti-inflammatory effects, supports wet healing and suppresses microbial colonization of the wound. HemaGel New is intended for the healing of acute wounds, such as superficial wounds, including 1st and 2nd-degree burns and postoperative wounds, and is also suitable for the healing of chronic wounds such as shin centres, bedsores and skin defects of patients with diabetes. The company VH Pharma is planning to launch other medicinal devices in the form of the HemaCut SPRAY.

Read more here.

Read also

• Czech Scientists Record Electrical Discharge on Mars Resembling Terrestrial Lightning
• Nuclear Physics Institute of the CAS Reaches Key Milestone in AlphaStar Project
• The Science Communication 360° conference will bring the Head of communications of the Max Planck Society
• Research reveals a previously unknown mechanism of genetic transcription
• Warming weakens natural enemies of insects, new research shows
• Hope for rare anemia patients: Czech scientists create "perfect" mouse model
• Czech Researchers Contribute to SOLAO Project on Soil-Transmitted Parasites
• Scholars from the Czech Academy of Sciences will help make key UN documents on refugee policy in post-communist Europe accessible
• New perspective on the climate crisis: an ERC Consolidator grant
• World first for Czech science: egg ageing can be reversed